Transcription of APREPITANT FOR CHEMOTHERAPY-INDUCED …
{{id}} {{{paragraph}}}
Example: tourism industry
APREPITANT FOR CHEMOTHERAPY-INDUCED …
Apre pitant fo r CHEMOTHERAPY-INDUCED Em esis (NCD ) Page 1 o f 5 UnitedHealthcare Medicare Advantage Policy Guideline Approved 10/09/2019 Proprietary Information of UnitedHealthcare. Copyright 2019 United HealthCare Services, Inc. APREPITANT FOR CHEMOTHERAPY-INDUCED EMESIS (NCD ) Guideline Number: Approval Date: October 9, 2019 Table of Contents Page POLIC Y APPLIC ABLE C ODES ..3 PURPOSE ..3 REFERENC GUIDELINE HISTORY/REVISION INFORMATION ..4 TERMS AND POLIC Y SUMMARY Overview C hemotherapy- induced nausea and vomiting (C INV) can range from mild to severe, with the most severe cases resulting in dehydration, malnutrition, metabolic imbalances, and potential withdrawal from future chemotherapy treatments. The incidence and severity of CINV are influenced by the specific chemotherapeutic agent(s) used; dosage, schedule and route of administration; and drug combinations.
Chemotherapy-induced nausea and vomiting (CINV) can range from mild to severe, with the most severe cases resulting in dehydration, malnutrition, metabolic imbalances, and potential withdrawal from future chemotherapy
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Antiemetic, Chemotherapy Induced Nausea and, Chemotherapy, ROPPHA Guideline for the Prevention, Prevention of Chemotherapy Induced Nausea and, Chemotherapy- induced nausea and, Chemotherapy-induced Nausea and Vomiting, Preventing Chemotherapy-Induced Nausea and, Updates in Chemotherapy-Induced Nausea and, Updates in Chemotherapy-Induced Nausea and Vomiting, CHEMOTHERAPY-INDUCED, Chemotherapy-Induced Nausea and, Integrating Clinical Guidelines into Patient, Symptom Management Guidelines: CANCER, Symptom Management Guidelines: CANCER RELATED NAUSEA, Nausea